Generex Biotechnology Corp. (GNBT) News Nov 14, 2014, 8:10

New Post Public Reply Private Reply Replies (0) Message Board

Nov 16, 2014 at 9:40 PM

Generex Biotechnology Corp. (GNBT) News Nov 14, 2014, 8:10 p.m.
MarketWatch News on GNBT
Wednesday’s biggest gaining and declining stocks 5:20 p.m. Oct. 20, 2010 - Kate Gibson
Progress on Diabetes, Cancer Treatments 6:04 p.m. Jan. 14, 2010 - Alexander Davis
Sunesis, Generex, Cubist lead drug stocks higher 1:29 p.m. Dec. 14, 2009 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 4:25 p.m. Dec. 9, 2009 - MarketWatch
Drug stocks trend lower; Pfizer, Dynavax gain 2:34 p.m. Dec. 9, 2009 - Val Brickates Kennedy
Thursday's biggest gaining and declining stocks 4:33 p.m. Dec. 3, 2009 - MarketWatch
Endo falls on FDA move; Generex rallies 12:25 p.m. Dec. 3, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 5:00 p.m. Sept. 11, 2009 - MarketWatch
Thursday's biggest gaining and declining stocks 4:17 p.m. Sept. 10, 2009 - MarketWatch
Dynavax, Generex rocket as drug stocks gain 1:23 p.m. Sept. 10, 2009 - Val Brickates Kennedy
Drug stocks inch lower while broader market gains 2:27 p.m. June 4, 2009 - Val Brickates Kennedy
Vaccine makers get boost from flu scare 12:20 p.m. May 21, 2009 - Val Brickates Kennedy
Pigs will get slaughtered on swine-flu stocks 5:27 p.m. April 30, 2009 - Chuck Jaffe
Shares of antiviral drugmakers rocket on flu news 12:54 p.m. April 27, 2009 - Val Brickates Kennedy
Niche antiviral drugmakers rocket on flu news 9:08 a.m. April 27, 2009 - Val Brickates Kennedy
As diabetes surges, the search for better treatments intensifies 4:33 p.m. Nov. 25, 2008 - Sara Sargent
Generex Bio says share decline linked to Eli Lilly, Novo Nordisk moves 7:20 a.m. March 11, 2008 - Dow Jones
Drug stocks slide; Mannkind, Alkermes fall for second day 3:48 p.m. March 10, 2008 - Val Brickates Kennedy
CORRECTS: Some small-cap stocks may get hit in '08, but not all 6:18 p.m. Jan. 16, 2008 - MarketWatch
The big picture is often misleading on stocks 8:05 a.m. Jan. 16, 2008 - Chuck Jaffe
Loading more headlines...
Advertisement
Other News on GNBT
10-K: GENEREX BIOTECHNOLOGY CORP 3:05 p.m. Oct. 3, 2014 - Edgar Online - (EDG = 10Q, 10K)
With Ebola Looming, When Will The Defense Department Get Around To Generex? 2:22 a.m. Oct. 1, 2014 - Seeking Alpha
10-Q: GENEREX BIOTECHNOLOGY CORP 3:14 p.m. June 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Provectus: Strong Sell, Ties To Paid Stock Promoters, SEC Halt Risk, Price Target $0 9:40 a.m. May 21, 2014 - Seeking Alpha
Provectus: Ties To Paid Stock Promoters, SEC Halt Risk, History Of Shareholder Wipeouts 9:40 a.m. May 21, 2014 - Seeking Alpha
Generex registers convertible shares 3:21 p.m. April 4, 2014 - Seeking Alpha
10-Q: GENEREX BIOTECHNOLOGY CORP 4:03 p.m. March 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Emerging Biotech Takes Aim At Preventing Recurrent Breast Cancer 10:12 a.m. Jan. 21, 2014 - Seeking Alpha
10-Q: GENEREX BIOTECHNOLOGY CORP 4:40 p.m. Dec. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Generex: A Stock Suitable Only For Its Officers And Directors Or Carl Icahn 10:08 a.m. Dec. 2, 2013 - Seeking Alpha
10-K: GENEREX BIOTECHNOLOGY CORP 3:39 p.m. Oct. 11, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: GENEREX BIOTECHNOLOGY CORP 4:05 p.m. June 10, 2013 - Edgar Online - (EDG = 10Q, 10K)
Stocks at New Highs, News Lows for 12/3 4:33 a.m. Dec. 3, 2012 - InvestorPlace.com
Weekly CFO Sells Highlight: TDG, GNBT, ADGE, HFC, AMSWA 3:20 p.m. July 2, 2012 - GuruFocus.com
An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA) 6:14 a.m. May 18, 2012 - 247WallSt.com
Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN) 11:00 a.m. May 10, 2012 - 247WallSt.com
Generex Biotechnology Corp. Reports Operating Results (10-Q) 4:47 p.m. Dec. 12, 2011 - GuruFocus.com
Weekly Healthcare Stock Watch 10:01 a.m. Oct. 5, 2011 - Seeking Alpha
Generex Corporate Update: The potential Is there 9:11 a.m. Aug. 4, 2011 - Seeking Alpha
Stocks To Watch This Week: DNDN, MNKD, CLDX 3:35 a.m. June 27, 2011 - Seeking Alpha
Loading more headlines...
Press Releases on GNBT
Generex Announces Presentation at the Society for Immunotherapy of Cancer Demonstrating that Induction of Antibody Response in Patients Receiving the AE37 Breast Cancer Vaccine Correlates with Reduced Relapse 9:30 a.m. Nov. 11, 2014 - PR Newswire - PRF
Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 8:30 a.m. Oct. 27, 2014 - PR Newswire - PRF
Generex / Antigen Express to Participate in 2014 BIO-Europe® Annual International Partnering Conference 8:30 a.m. Oct. 23, 2014 - PR Newswire - PRF
Generex Announces Publication of Ebola Vaccine White Paper by Antigen Express 8:30 a.m. Oct. 21, 2014 - PR Newswire - PRF
Generex Clarifies Utility of Antigen Express Technology for Potential Ebola Vaccine 8:30 a.m. Oct. 7, 2014 - PR Newswire - PRF
Generex Announces Engagement of Dr. Lakshmi P. Kotra for Buccal Insulin Enhancement Project 8:30 a.m. Sept. 30, 2014 - PR Newswire - PRF
Generex Collaborates with University Health Network for Buccal Insulin Project 8:30 a.m. Sept. 22, 2014 - PR Newswire - PRF
Generex / Antigen Express to Participate in BioPharm America™ 2014 8:15 a.m. Sept. 3, 2014 - PR Newswire - PRF
Generex Announces Publication of AE37 Prostate Cancer Vaccine Study 8:30 a.m. Aug. 6, 2014 - PR Newswire - PRF
Generex Announces Interview of Dr. Eric von Hofe, President of Antigen Express, Following Recent Keynote Presentation 8:30 a.m. June 17, 2014 - PR Newswire - PRF
Generex/Antigen Express Announce Interview of MD Anderson's Dr. Elizabeth Mittendorf, Principal Investigator on Company's AE37 Phase IIb Breast Cancer Efficacy Trial 8:30 a.m. June 12, 2014 - PR Newswire - PRF
Generex / Antigen Express to Participate in 2014 BIO International Convention 8:30 a.m. June 10, 2014 - PR Newswire - PRF
Generex Announces Presentation of Primary Efficacy Data & Immunological Response from the Phase II Study of AE37 Cancer Vaccine at ASCO 8:30 a.m. May 20, 2014 - PR Newswire - PRF
Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting 8:30 a.m. April 23, 2014 - PR Newswire - PRF
Generex Announces $2,075,000 Capital Investment 8:30 a.m. March 27, 2014 - PR Newswire - PRF
Generex/Antigen Express Announces Participation on Panel at Upcoming Cancer Immunotherapeutics Symposium 8:30 a.m. March 26, 2014 - PR Newswire - PRF
Generex Biotechnology Corp. Granted Patents on New HPV and Influenza Vaccines 11:01 a.m. March 12, 2014 - ACCESSWIRE
Generex Subsidiary Antigen Express Receives Patents for Vaccines Targeting HPV Induced Cancers and Influenza 9:30 a.m. March 5, 2014 - PR Newswire - PRF
Generex Announces Publication of Biomarker Studies Related to the Antigen Express Novel Immunotherapeutic AE37 in Prostate Cancer Patients 9:30 a.m. Feb. 27, 2014 - PR Newswire - PRF
Generex/Antigen Express Interview on Clear Channel Business Talk Radio DFW 1190AM by Host Michael Yorba 10:27 a.m. Feb. 12, 2014 - Marketwire
Loading more headlines...

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

China's 15th Plan: Key Moves in the Capital Markets

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

CStone's CS2009: A Leap in Cancer Treatment Validated

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

NOTHING NINE's Global Ambitions: Paris Show's Impact

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...

Ambient AI Shows Promise for Boosting Cancer Care Efficiency

Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...

Superteam Wheels Rides Into Spain with RACEIT Deal

Rolling Out the Red Carpet for Spanish Cyclists Think of it as the pedal-powered bridge from wherever Superteam Wheels calls home to the sunny streets of Spain. If you're in the cycling game, this new partnership between Superteam Wheels and COMERTECH RACEIT, S.L., better known as RACEIT, is drawing a line in the sand—or perhaps on the asphalt—across Europe. Starting...

Zinzino Eyes European Market With New Botanical Line

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

HCLTech Partners with Rapidus on Semiconductor Future

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

ASICS and University of Michigan Launch Innovation Lab

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Ivonescimab Promises New Hope for Advanced BTC Patients

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...